Inspire Medical Systems (INSP) Capital Expenditures (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inspire Medical Systems | 1.17 Bn | 889.44 Mn | 176.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,143.28% |
| Dec 31, 2025 | 11.85% |
| Sep 30, 2025 | -121.45% |
| Jun 30, 2025 | -23.07% |
| Mar 31, 2025 | 4,774.29% |
| Dec 31, 2024 | 83.01% |
| Sep 30, 2024 | 74.09% |
| Jun 30, 2024 | -129.13% |
| Mar 31, 2024 | -32.06% |
| Dec 31, 2023 | 14.95% |
| Sep 30, 2023 | 43.93% |
| Jun 30, 2023 | 29.36% |
| Mar 31, 2023 | 192.01% |
| Dec 31, 2022 | -182.67% |
| Sep 30, 2022 | 164,566.67% |
| Jun 30, 2022 | -100.25% |
| Mar 31, 2022 | 131.47% |
| Dec 31, 2021 | -435.45% |
| Sep 30, 2021 | -30.79% |
| Jun 30, 2021 | 25.89% |
| Mar 31, 2021 | 118.71% |
| Dec 31, 2020 | -50.29% |
| Sep 30, 2020 | 218.90% |
| Jun 30, 2020 | 49.41% |
| Mar 31, 2020 | 111.10% |
| Dec 31, 2019 | -315.88% |
| Sep 30, 2019 | 11.06% |
| Jun 30, 2019 | 248.36% |
| Mar 31, 2019 | 43.98% |
| Jun 30, 2018 | 642.86% |
| Mar 31, 2018 | -88.71% |
| Dec 31, 2017 | -50.00% |
| Sep 30, 2017 | 520.00% |
| Jun 30, 2017 | -90.29% |